XOMA announced the first presentation of results from its discovery of two new classes of fully human monoclonal antibod…
XOMA
XOMA Type 2 Diabetes Drug Fails to Meet End Point in Phase 2 Trials
XOMA Ltd. announced that its phase 2b trial of XOMA 052 in type 2 diabetes patients did not achieve the primary endpoint…
